Advertisement

‘Friends’ Actor James Michael Tyler, Who Played Gunther, Reveals Stage 4 Prostate Cancer Diagnosis

William Earl
·2-min read

James Michael Tyler, who portrayed Central Perk employee Gunther on “Friends,” has revealed his Stage 4 prostate cancer diagnosis. He shared the news on “Today” on Monday morning.

“I was 56 years old at the time, and they screen for PSA, which is prostate-specific antigen,” Tyler said. “That came back at an extraordinarily high number. So I knew immediately when I went online and I saw the results of my blood test and blood work that there was obviously something quite wrong there. Nearly immediately, my doctor called me and said, ‘Hey, I need you to come in tomorrow because I suspect that you may have quite a serious problem with your prostate.'”

More from Variety

Tyler was recently seen on the HBO Max special “Friends: The Reunion.” While several other characters from the show stopped by to say hello to the core cast in person, Tyler appeared via video conference.

“I wanted to be a part of that, and initially I was going to be on the stage, at least, with them, and be able to take part in all the festivities,” he said. “It was bittersweet, honestly. I was very happy to be included. It was my decision not to be a part of that physically and make an appearance on Zoom, basically, because I didn’t wanna bring a downer on it, you know? I didn’t want to be like, ‘Oh, and by the way, Gunther has cancer.'”

The actor is undergoing chemotherapy to combat the cancer, and is urging men to get early screenings in order to battle it through an early diagnosis.

“There are other options available to men if they catch it before me,” he said. “Next time you go in for just a basic exam or your yearly checkup, please ask your doctor for a PSA test. It’s easily detectable. If it spreads beyond the prostate to the bones, which is most prevalent in my form, it can be a lot more difficult to deal with.”

Watch Tyler’s interview on “Today” below:

Best of Variety

Sign up for Variety’s Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.